SEC Form D private-offering filing

Akelos, Inc.

Name: Akelos, Inc. - new SEC Form D private-offering filing, New York, NY
Published: 2026-03-16

A new SEC Form D private-offering notice from New York, NY, an undisclosed offering target in Biotech. The source filing is one click away.

Akelos, Inc. site↗ Verified via SEC Form D

Biopharmaceutical company developing non-opioid, anti-hyperalgesic drugs for neuropathic pain, in research collaboration with Weill Cornell Medicine.

Filed 2026-03-16Filed to raise UndisclosedFirst money in 2026-03-09Raised so far $1,486,000HQ (as filed) New York, NYSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified akelosinc.com↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.